We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Mirati Therapeutics Inc | NASDAQ:MRTX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 58.70 | 58.90 | 58.70 | 0 | 01:00:00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
|
001-35921
|
|
46-2693615
|
(State of incorporation)
|
|
(Commission File No.)
|
|
(IRS Employer Identification No.)
|
|
|
Item 2.02
|
Results of Operations and Financial Condition.
|
Item 9.01
|
Financial Statements and Exhibits.
|
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
Press Release dated August 3, 2017
|
|
|
|
|
Date: August 3, 2017
|
|
Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
By:
|
/s/ Jamie A. Donadio
|
|
|
|
Jamie A. Donadio
|
|
|
|
Senior Vice President and Chief Financial Officer
|
|
|
|
Exhibit No.
|
|
Description
|
99.1
|
|
Press Release dated August 3, 2017.
|
1 Year Mirati Therapeutics Chart |
1 Month Mirati Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions